CMO

BETSWAP.GG UNVEILS MAJOR PLATFORM UPGRADE & EXCEPTIONAL GROWTH FIGURES

Retrieved on: 
Wednesday, May 1, 2024
Web 2.0, Decentralized finance, Testnet, GGR, CMO, Very important person, Gambling, Traction, Noise, Web3

WILLEMSTAD, Curacao, May 1, 2024 /PRNewswire/ -- Betswap.gg, the pioneering hybrid sports trading exchange that merges Web2 and Web3 technologies, today announced a major upgrade to its casino and main site.

Key Points: 
  • WILLEMSTAD, Curacao, May 1, 2024 /PRNewswire/ -- Betswap.gg, the pioneering hybrid sports trading exchange that merges Web2 and Web3 technologies, today announced a major upgrade to its casino and main site.
  • Since the launch of its Testnet in September 2022, Betswap.gg has evolved into a highly dynamic platform catering to both crypto enthusiasts and traditional bettors.
  • "These figures are a testament to the scalability and appeal of our platform," added Ameen.
  • The platform continues to make significant strides, gaining traction and making noise across the industry.

Parks Associates: 77% of Internet Households Participate in Free Loyalty Programs

Retrieved on: 
Wednesday, May 1, 2024
Circle, CMO, Internet, Interview, Daisy, Conference, OTT

DALLAS, May 1, 2024 /PRNewswire/ -- Parks Associates' new consumer study of 8,000 US internet households, Subscription Memberships and Bundles: Shopping, Video, Gaming, Mobile, reveals 77% of US internet households participate in free loyalty programs, led by high-transaction providers such as grocery stores (45%) and credit cards (42%). This landmark study of the subscription economy explores current adoption of membership and subscription programs and opportunities to leverage these preexisting relationships to create new bundles and paid services.

Key Points: 
  • DALLAS, May 1, 2024 /PRNewswire/ -- Parks Associates' new consumer study of 8,000 US internet households, Subscription Memberships and Bundles: Shopping, Video, Gaming, Mobile , reveals 77% of US internet households participate in free loyalty programs, led by high-transaction providers such as grocery stores (45%) and credit cards (42%).
  • Parks Associates will explore these strategies at its upcoming CONNECTIONS™: The Premier Connected Home Conference , May 7-9 at the Hilton Dallas/Plano Granite Park Hotel in Plano, TX .
  • "Entertainment, convenience, resources, and discount/value are primary value propositions for subscription and membership services," said Elizabeth Parks , President and CMO, Parks Associates.
  • Free loyalty programs can be an onramp to paid memberships.

Foresight Diagnostics Co-Founder Dr. David Kurtz Joins Company as Chief Medical Officer and Head of Research

Retrieved on: 
Wednesday, May 1, 2024
Neoplasm, Stanford University, Foresight, Genomics, CMO, College of Engineering (KNUST), MRD, Doctor of Philosophy, Lymphoma, Entrepreneurship, DNA, Translation, Principal, Circulating tumor DNA, Assistant, Molecular biology, Growth, Liquid biopsy

BOULDER, Colo., May 1, 2024 /PRNewswire/ -- Foresight Diagnostics™, a leading diagnostics company specializing in the development of ultra-sensitive minimal residual disease (MRD) detection, announced today the appointment of David Kurtz, MD, PhD, as its new Chief Medical Officer (CMO) and Head of Research.

Key Points: 
  • BOULDER, Colo., May 1, 2024 /PRNewswire/ -- Foresight Diagnostics™, a leading diagnostics company specializing in the development of ultra-sensitive minimal residual disease (MRD) detection, announced today the appointment of David Kurtz, MD, PhD, as its new Chief Medical Officer (CMO) and Head of Research.
  • "We are thrilled to have Dr. Kurtz join Foresight to lead our research and development efforts and steer our medical affairs strategy," said Jake Chabon, CEO and Co-Founder of Foresight.
  • During this time, Dr. Kurtz ran an independent research laboratory focused on translational genomics.
  • Clinically, Dr. Kurtz is a medical oncologist who specializes in the treatment of non-Hodgkin lymphomas.

Splash to Expand Event Management Capabilities with Guidebook Integration

Retrieved on: 
Wednesday, May 1, 2024
Google Play, Communication, Marketing, ROI, CMO, Interview, Analytics, Leading, Social media, App Store (iOS/iPadOS), Q&A, Mobile phone

NEW YORK, May 1, 2024 /PRNewswire/ -- Splash, a global event marketing technology company, today announced its upcoming integration with Guidebook, a leading app builder for events. The integration, which will be generally available to customers in June, will help Splash users enhance attendee engagement with easier access to event information, improved on-site communication, and more opportunities to build networking connections.

Key Points: 
  • Integration with Leading Event App Platform to Enhance Attendee Engagement, Drive Better On-Site Communication
    NEW YORK, May 1, 2024 /PRNewswire/ -- Splash , a global event marketing technology company, today announced its upcoming integration with Guidebook , a leading app builder for events.
  • When a Splash customer enables the Guidebook integration and creates an event mobile app, they optimize event communication for event hosts and their attendees.
  • The Splash and Guidebook integration will help event organizers streamline their operations, while supporting more audience engagement."
  • Splash is hosting a virtual product launch event featuring the Guidebook integration at 12 pm ET on Tuesday, May 21, 2024.

Eluminex Biosciences Announces FDA Acceptance of Investigational New Drug (IND) Application for EB-105 - A Novel Trispecific Fusion Antibody for Diabetic Macular Edema (DME) - and Upcoming Scientific Presentations

Retrieved on: 
Tuesday, April 30, 2024
FDA, Inflammation, CMO, VEGF-A, Clinical trial, Food, Diabetic retinopathy, Doctor of Philosophy, IND, Therapy, Ranibizumab, Senior, Patient, Master of Science, Pediatrics, Summit Meeting, Season, DME, IL-6, JZ, SAN

EB-105 is a novel trispecific fusion antibody targeting VEGF-A (and isomers), VEGF-B, placental growth factor (PlGF), angiopoetin-2 (Ang-2), and interleukin-6 receptor (IL-6R) for the treatment of DME.

Key Points: 
  • EB-105 is a novel trispecific fusion antibody targeting VEGF-A (and isomers), VEGF-B, placental growth factor (PlGF), angiopoetin-2 (Ang-2), and interleukin-6 receptor (IL-6R) for the treatment of DME.
  • "Elevated levels of IL-6 in the vitreous have been well-documented in patients with DME, even with on-going anti-VEGF treatments.
  • Furthermore, IL-6 is over-expressed and contributes to inflammation and vascular permeability in other retinal disorders including neovascular (wet) age-related macular degeneration, retinal vein occlusion, and uveitic macular edema.
  • Details of EB-105 mechanism of action and preclinical science will be presented at the following venues:
    Oral presentation.

LaserAway - Nation's Leading Aesthetic Dermatology Company - Adds Former Orangetheory CMO and Amazon Exec Kelly Lohr as Chief Customer Officer

Retrieved on: 
Monday, April 29, 2024
University, Orangetheory Fitness, Rejuvenation, Patient, CMO, Moses Austin, Health, Marketing, Amazon Go, Nursing, Family, Nestlé, Acquisition, Medicine, Growth, Head

LOS ANGELES, April 29, 2024 /PRNewswire/ --The nation's leading aesthetic dermatology chain, LaserAway, has hired Kelly Lohr as its first-ever Chief Customer Officer. Overseeing the end-to-end customer journey – including customer acquisition and customer engagement, retention, and loyalty – Lohr joins after serving as Chief Marketing Officer at fitness giant Orangetheory Fitness and holding executive marketing roles at Freshly and Amazon. Already in 145 locations, LaserAway will benefit from Lohr's expertise in scaling health and wellness brands.

Key Points: 
  • LOS ANGELES, April 29, 2024 /PRNewswire/ --The nation's leading aesthetic dermatology chain, LaserAway, has hired Kelly Lohr as its first-ever Chief Customer Officer.
  • Overseeing the end-to-end customer journey – including customer acquisition and customer engagement, retention, and loyalty – Lohr joins after serving as Chief Marketing Officer at fitness giant Orangetheory Fitness and holding executive marketing roles at Freshly and Amazon.
  • In just the past four years, we've experienced remarkable demand for our services," LaserAway Co-Founder and CEO Scott Heckmann said.
  • Prior to her role as CMO at Orangetheory, Lohr was Chief Growth Officer at Freshly, the Nestle-owned healthy prepared meal delivery subscription service.

COCA Announces the Launch of Points System at Money20/20 Asia

Retrieved on: 
Monday, April 29, 2024
MPC, CMO, Social, Ecosystem, Social media, News, Content creation, USDT, Creativity, Cryptocurrency

BANGKOK, April 29, 2024 /PRNewswire/ -- COCA , the world's first MPC wallet with a non-custodial debit card, announced the launch of COCA Points System at Money20/20 Asia, following its acceptance into the Money20/20 Startups' Hangout program .

Key Points: 
  • BANGKOK, April 29, 2024 /PRNewswire/ -- COCA , the world's first MPC wallet with a non-custodial debit card, announced the launch of COCA Points System at Money20/20 Asia, following its acceptance into the Money20/20 Startups' Hangout program .
  • The first season of the COCA Points System brings exciting opportunities for users to earn rewards through various activities:
    - Interactive Engagement on Social Media: Join the COCA community on social media platforms, participate in discussions, and stay updated with the latest news to earn points.
  • - Rewards for Using the COCA App and Card: Every interaction within the app, including asset swaps and transactions, earns points.
  • Additionally, using the COCA card for transactions rewards users with points.

COCA Announces the Launch of Points System at Money20/20 Asia

Retrieved on: 
Monday, April 29, 2024
MPC, CMO, Social, Ecosystem, Social media, News, Content creation, USDT, Creativity, Cryptocurrency

BANGKOK, April 29, 2024 /PRNewswire/ -- COCA , the world's first MPC wallet with a non-custodial debit card, announced the launch of COCA Points System at Money20/20 Asia, following its acceptance into the Money20/20 Startups' Hangout program .

Key Points: 
  • BANGKOK, April 29, 2024 /PRNewswire/ -- COCA , the world's first MPC wallet with a non-custodial debit card, announced the launch of COCA Points System at Money20/20 Asia, following its acceptance into the Money20/20 Startups' Hangout program .
  • The first season of the COCA Points System brings exciting opportunities for users to earn rewards through various activities:
    - Interactive Engagement on Social Media: Join the COCA community on social media platforms, participate in discussions, and stay updated with the latest news to earn points.
  • - Rewards for Using the COCA App and Card: Every interaction within the app, including asset swaps and transactions, earns points.
  • Additionally, using the COCA card for transactions rewards users with points.

EQS-News: Asklepios Group: Asklepios shows resilience in 2023 financial year

Retrieved on: 
Friday, May 3, 2024
CFO, CMO, Investment, EAT, Hospital, Nursing, Psychiatry, Heart, Patient, Social responsibility, PD

Despite the challenges arising from persistent inflation and structural uncertainties in the healthcare sector, Asklepios Kliniken GmbH & Co. KGaA closed the 2023 financial year with sound results and demonstrated its economic resilience.

Key Points: 
  • Despite the challenges arising from persistent inflation and structural uncertainties in the healthcare sector, Asklepios Kliniken GmbH & Co. KGaA closed the 2023 financial year with sound results and demonstrated its economic resilience.
  • The 2023 financial year was influenced by a challenging regulatory environment, general cost inflation and price increases triggered by the ongoing war in Ukraine.
  • The Asklepios Group treated approximately 3.5 million patients at its 164 healthcare facilities in the 2023 financial year.
  • Around 3.5 million patients were treated at the Asklepios Group’s facilities in the 2023 financial year.

EQS-News: CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update

Retrieved on: 
Friday, May 3, 2024
University, Part, CMO, Federal republic, Research, Cancer, Federal Patent Court (Germany), Vaccine, Business, Webcast, BioNTech, District court, Whole genome sequencing, Vaccination, Public, WHO, Hearing loss, Cardiology, Animal, EP 1, Omicron, GSK, Systems biology, Workforce, Infection, Messenger, Federal court, Therapy, Data monitoring committee, Safety, Monroe Dunaway Anderson, CVAC, Justice, RNA, Astrocytoma, Motion, Human, CureVac, Pandemic, GMP, Sąd rejonowy, SARS-CoV-2, Business development, Epitope, MD, Acuitas Therapeutics, DSMB, Ageing, Patent, Patient, Neurology, Operating cost, H5N1, MD Anderson Cancer Center, PPA, Interim, MBA, Antigen, COVID-19, Amgen

ET / 3 p.m. CET

Key Points: 
  • ET / 3 p.m. CET
    TÜBINGEN, Germany/BOSTON, USA – April 24, 2024 – CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced financial results for the fourth quarter and full-year 2023 and provided a business update.
  • “We closed out 2023 on a sturdy footing and are poised to advance strongly through 2024 with strategic initiatives to make CureVac fit-for-purpose.
  • Thaminda Ramanayake was appointed to the CureVac Management Team as Chief Business Officer effective June 1, 2024.
  • Mr. Ramanayake joins CureVac from Affini-T Therapeutics, where he served as Chief Business Officer and was responsible for creating the company’s business development organization.